This health care selloff shows the value of diversification to protect our portfolios -- and to go on the offensive and find bargains.
The free press that the progressive push for Medicare got on Tuesday morning is hurting the healthcare sector.
UNH's operational strength can't overcome the potential political overhang at the moment.
The health benefit giant's fundamentals are good, but there are more symptoms to consider for a proper examination.
A low-risk countertrend options trade may be worth a look in this name.
The way I do that is by using buy-write option strategies.
Healthcare giants Johnson & Johnson and Pfizer offer a tough choice for dividend investors seeking the best returns.
Look at the entirety of your portfolio and make sure there are no earnings blow-ups coming from the companies that you own.
In fact, the de-emphasizing of cigarettes was blamed for declining same store sales.
The contagion in pharmacy stocks is spreading and secular trends aren't helping to find a solution anytime soon.